Increased arterial stiffness is strongly associated with atherosclerosis, while platelet activation is an important trigger of thrombotic events in patients with atherosclerosis. However, little is known about the effect of arterial stiffness on platelet activation. We therefore investigated the association between arterial stiffness and platelet activation in 38 normal volunteers (20 men and 18 women) aged 23-77 years (mean ¼ 49715 years). Arterial stiffness was assessed by measuring brachialankle pulse wave velocity (ba-PWV) and heart-brachial PWV (hb-PWV). Flow cytometric analyses were performed to evaluate platelet activation by measuring surface expression of P-selectin and platelet-neutrophil complexes (PNC) before and after activation by ADP. We also calculated the difference between basal and stimulated states of P-selectin and PNC to assess platelet activation reserve. PWVs were significantly correlated with age and BP (r ¼ 0.60-0.81). For platelet activation and activation reserve, correlations with age were less strong but remained significant (r ¼ 0.36-0.61), with the exception of P-selectin (not significant, NS), and correlations with SBP were similar (r ¼ 0.35-0.53). A significant correlation was found between PWVs and platelet activation (r ¼ 0. 43-0.74). Multiple regression analysis demonstrated significant correlations between platelet activation and reserve and PWVs (coefficient ¼ 2.17-6.59), when both age and BP were adjusted for simultaneously. In conclusion, platelet activation was associated with arterial stiffness, suggesting that arterial stiffness may play an important role in thrombotic events.
Introduction
Platelet activation and aggregation are important triggers of thrombotic events in patients with atherosclerosis. In such patients, platelets are activated at the site of atheroma 1 due to increased shear stress in the narrowed vessels. 2, 3 Increased platelet activation is observed in patients with coronary risk factors and cardiovascular events. [4] [5] [6] [7] [8] [9] [10] [11] [12] Increased arterial stiffness, measured with pulse wave velocity (PWV), has been shown to be associated with atherosclerosis and risk factors of atherosclerotic cardiovascular disease, [13] [14] [15] [16] [17] [18] [19] [20] [21] and is an independent predictor of cardiovascular events, 22, 23 Therefore, although platelets are likely to be activated in patients with atherosclerotic disease who exhibit increased arterial stiffness, little is known about the relation of arterial stiffness itself to platelet activation.
Recently, platelet activation has been widely evaluated by measuring soluble P-selectin; a platelet surface molecule also termed CD62P. 4, [6] [7] [8] 11 Although the measurement of soluble P-selectin is simple and useful, it is an indirect method of evaluating platelet activation. On the other hand, platelet activation can be detected directly by measuring surface antigen CD62P using flow cytometry. 2, 3, 5, 9, 10, 12 Furthermore, detection of platelet-neutrophil complexes (PNC), which are formed as a result of interaction with CD62P provides an additional means to detect platelet activation. 24 The purpose of this study was to investigate the association between arterial stiffness and platelet activation by measuring PWV, P-selectin, and PNC in subjects without atherosclerotic disease.
Materials and methods

Subjects
We studied 38 healthy nonsmoking volunteers (20 men and 18 women), aged 23-77 years (mean ¼ 49715 years) with no evidence of heart disease on physical examination, standard 12-lead electrocardiography, chest radiography, echocardiography, or blood chemistry analysis. Subjects had no self-reported past history or current evidence of cardiovascular disease, hypertension, hypercholesterolaemia, diabetes mellitus or renal disease. Basic characteristics of subjects are shown in Table 1 . None of the subjects had frequent ectopic beats or atrial fibrillation and none had taken any medication for at least 10 days. Informed consent was obtained before performing the study and the study protocol was approved by the Local Ethics Committee of Kochi Medical School.
Evaluation of arterial stiffness
Arterial stiffness was evaluated by PWV, measured using volume-plethysmographic apparatus (Colin, Komaki, Japan). [18] [19] [20] [21] Data were acquired with subjects lying supine in a quiet and temperaturecontrolled room at 11 AM, at least 3 h after breakfast. Surface electrodes were attached to both wrists for ECG measurement, a microphone was positioned at the left sternal edge to detect heart sounds, and cuffs incorporating plethysmographic and oscillometric sensors were fastened around both the brachial regions and ankles to measure pulse wave forms and blood pressure. Brachial-ankle PWV (ba-PWV) and heart-brachial PWV (hb-PWV) were measured as follows. The time interval between the wave foot of the brachial waveform and that of the ankle waveform was defined as the time interval between the brachial region and ankle, while the time interval between the heart and the right brachial artery was defined as the time interval between the second heart sound and the right brachial waveform. The distance between these sampling points was calculated automatically according to the height of the subject. PWVs were calculated by dividing each distance by the respective time interval. Right brachial blood pressure (systolic and diastolic) and pulse rate were concurrently measured.
Measurement of platelet activation
Sample preparation and measurement of platelet P-selectin (CD62P) and PNC levels were performed according to the method described by Peters et al. 24 To minimize platelet activation during blood collection, blood was drawn via a 21 G butterfly needle without the use of a tourniquet. After discarding the first 2 ml of blood, a further 2 ml was collected and immediately added to 200 ml of sodium citrate (3.13%). All antibodies were sourced as follows: Fluorescein isothiocyanate (FITC) labelled IgG1 anti-CD62P from Dainippon Pharmaceutical, Osaka, Japan, phycoerythin (PE) labelled IgG2a anti-CD42b and FITC labelled IgG1 anti-CD11b from Beckman Coulter, Fullerton, CA, USA. As negative controls, FITC-labelled IgG1 (Beckman Coulter, Fullerton, CA, USA) and double-stained (FITC/PE) IgG1 and IgG2a (Dako, High Wycombe, Bucks, UK) irrelevant antibodies were included.
Sample preparation for the measurement of platelet CD62P level: In all, 5 ml of blood was added to a round-bottomed polystyrene tube containing 50 ml of platelet buffer (10 mmol/l HEPES, 145 mmol/l NaCl, 5 mmol/l KCl, 1 mmol/l MgSO 4 ; pH 7.4), and 5 ml of anti-CD62P or control IgG1 antibody. Following gentle suspension, samples were incubated in the dark at room temperature for 20 min without stirring. Then 250 ml of fixative was added and the tubes were incubated for an additional 10 min. The samples were then diluted with 500 ml of buffer and analysed. Flow cytometric analysis was performed within 1 h of fixation.
Sample preparation for the measurement of PNC level: In all, 50 ml of blood was added to a roundbottomed polystyrene tube containing 5 ml of antiCD42b, and 5 ml of anti-CD11b or isotype control antibodies. Following gentle mixing, samples were incubated in the dark at room temperature for 10 min without stirring. Then 500 ml of fixative was added and the tubes were incubated for additional 10 min. Flow cytometric analysis was performed within 1 h of preparation.
Flow cytometric analysis
Blood samples were analysed in a COULTER EPICS XL Profile Flow Cytometer, Miami, FL, USA, using either single or double fluorochromes. The peak emission intensity of FITC fluorescence was 
hb-PWV ¼ heart-brachial pulse wave velocity; ba-PWV ¼ brachial-ankle pulse wave velocity.
Arterial stiffness and platelet activation F Yamasaki et al detected at 515 nm and that of phycoerythin fluorescence at 580 nm. Measurement of platelet CD62P level: After forward and side scatter measurements were made with gain setting in logarithmic mode, platelet-sized events were counted. CD62P-positive platelets were defined as those with a fluorescence intensity exceeding that of 98% of the platelets staining with control antibody.
Measurement of PNC level: After forward and side scatter measurements were made with gain setting in linear mode, neutrophil-sized events were selected. Results were defined as positive when the fluorescence intensity exceeded that of 98% of the isotype-matched (IgG1 and IgG2a) control antibodies staining. Events positive for both CD11b and CD42b were considered to represent PNCs and were expressed as percentages of events with positive CD11b staining.
Evaluation of platelet activation reserve: We evaluated platelet activation reserve, that is, the ability of the platelets to be activated, in a separate experiment. Platelets were activated with 5 ml of adenosine diphosphate (ADP). We also calculated the difference between basal and stimulated states of P-selectin expression (D-P-selectin) and PNC level (D-PNC) to determine activation reserve.
Statistical analysis
Data are presented as mean7s.d. Univariate linear correlation analysis and multiple regression analysis were used for statistical evaluation. The variables significantly associated with platelet activation on univariate analysis were included in a multiple regression analysis in order to adjust PWV for each variable. Gender differences were evaluated with ANOVA. P-values o0.05 were considered to represent statistical significance.
Results
Both ba-PWV and hb-PWV exhibited significant positive correlations with age, systolic, and diastolic blood pressure (r ¼ 0.60-0.81, Po0.05 or o0.01), and pulse rate (r ¼ 0.44, Po0.05, r ¼ 0.65, o0.01, respectively) ( Table 2 ). For platelet activation and activation reserve, correlations with age were less strong but remained significant (r ¼ 0.36-0.61, Po0.05 or o0.01) with the exception of D-P-selectin (not significant, NS), and correlations with systolic and diastolic blood pressure were similar (r ¼ 0.35-0.53, Po0.05 or o0.01) with the exception of P-selectin (NS) ( Table 3) . However, platelet activation and activation reserve exhibited no significant correlation with pulse rate, blood glucose, total cholesterol, blood urea nitrogen or creatinine. No significant gender-related differences were observed in any of these correlations (Tables 2 and 3 ).
PWVs exhibited significant positive correlations (r ¼ 0.43-0.74, Po0.05 or o0.01) to all indices of platelet activation and reserve (Table 4, Figure 1) . When age or blood pressures were adjusted for on multivariate analysis, some indices of platelet activation and reserve were significantly related to PWVs (r ¼ 0.34-7.67, Po0.05 or o0.01). When both age and blood pressures were simultaneously adjusted for, significant correlations remained between platelet activation and reserve and PWVs (r ¼ 2.17-6.59, Po0.05 or o0.01) ( Table 4) . In other words, although the relationship between PWVs and the indices of platelet activation was strongly affected by age and blood pressure, a significant association remained when these factors were adjusted for.
Discussion
The main finding of this study was that platelet activation and activation reserve were associated with arterial stiffness when analyses were adjusted for age and blood pressure. This suggests that increased arterial stiffness might play an important role in thrombotic events.
Patients with hypertension, cerebrovascular disease, coronary heart disease, diabetes mellitus, and renal failure are recognized to have less arterial compliance than normal subjects. [13] [14] [15] [17] [18] [19] Increased PWV has also been reported to be an independent predictor of cardiovascular events in patients with hypertension or renal failure, and in elderly subjects. 22, 23 The association between increased arterial stiffness and high incidence of cardiovascular events may be explained by the existence of atherosclerosis. Hirai et al 25 have demonstrated strong associations between abdominal aortic and Arterial stiffness and platelet activation F Yamasaki et al carotid arterial stiffness and the degree of coronary artery disease. Popele et al 26 recently reported that aortic stiffness as measured by PWV is strongly associated with common carotid intima-media thickness, carotid arterial plaques, and the presence of peripheral arterial disease. Moreover, some population-based studies have demonstrated higher blood pressure, increased age, and male gender to be associated with increased PWV. 16, 20, 21 Pulse pressure may also relate to arterial stiffness and cardiovascular events, with higher pulse pressure reflecting elevated systolic pressure and reduced diastolic pressure due to increased arterial stiffness. In the present study, significant relationships were observed between PWVs and age, blood pressure, and pulse rate, in accordance with previous studies. 
hb-PWV ¼ heart-brachial pulse wave velocity; ba-PWV ¼ brachial-ankle pulse wave velocity. 'Not adjusted' -values are correlation coefficients between PWVs and indices of platelet activation before adjustment. *Po0.05. **Po0.01. Other values are regression coefficients between PWVs and indices of platelet activation adjusted for age and/or blood pressures as indicated. *Po0.05. **Po0.01.
Arterial stiffness and platelet activation F Yamasaki et al P-selectin is a component of a-granules that is expressed on the platelet surface membrane and released into the plasma upon platelet activation. Although the bulk of circulating soluble P-selectin appears to be platelet derived, 27 the substance is also found in the Weibel-Palade bodies of endothelial cells. 28 Direct measurement of platelet membrane P-selectin is therefore a more sensitive method of assessing platelet activation. In the present study, we evaluated platelet activation by measuring membrane activation markers using flow cytometry with activationdependent monoclonal antibodies. PNC levels were also measured using the same method. P-selectin levels in our normal subjects aged 49715 years were 13.171.7%; this was higher than that in quoted by other studies, possibly due to the differences in monoclonal antibodies or in sample manipulation.
P-selectin expressed on activated platelets causes formation of PNC. Moreover, platelets and plateletderived P-selectin play an important role in thrombus growth at the site of atherosclerosis.
2 In vivo and in vitro studies have shown that shear stress and exposure to atherogenic stimuli, such as oxidization by low-density lipoprotein or cigarette smoking, induce rapid P-selectin-dependent aggregation and accumulation of leukocytes and platelets. 4, 5, 11 Activated platelets accumulating in thrombi at the site of ruptured atherosclerotic plaques will express CD62P. In clinical studies, P-selectin has been shown to be a marker of platelet activation related to adverse cardiovascular events such as hypertension, coronary artery disease, cerebrovascular disease, and peripheral arterial disease, 6, 7, [10] [11] [12] and also to be a predictor of cardiovascular events. 8, 12 PNC, forming as a result of the interaction of platelet P-selectin and neutrophils also promotes platelet activation. 24 This is the first study to demonstrate that P-selectin and PNC were significantly correlated with arterial stiffness evaluated by PWV in normal subjects. In an analysis of four randomized trials, Hebert et al 29 showed that aspirin therapy was beneficial in the primary prevention of vascular disease. Higher levels of other membrane markers such as von Willebrand factor receptor are observed in activated platelets, which are affected by aspirin or ticlopidine. 30 Therefore, our results indicate that, in the normal population, antiplatelet agents may play a role in preventing cardiovascular events through factors other than P-selectin.
Although the exact mechanism accounting for the relationship between platelet activation and arterial stiffness is unknown, it is possible to make Arterial stiffness and platelet activation F Yamasaki et al the following speculations. When arterial stiffness is raised, shear stress might play an important role in platelet activation. Using cone-plate viscometry, 3 Goto et al showed that platelet activation (measured by P-selectin surface expression, von Willebrand factor-mediated platelet aggregation and translocation of GP Iba) was induced by high shear rate of 10 800 s À1 . Higher arterial stiffness increases blood flow velocity and produces a steep systolic pressure waveform, 31 and it is possible that the resulting increased shear stress could promote platelet activation. Another possible mechanism is that endothelial dysfunction may interact with arterial stiffness and platelet hyperactivity. Kobayashi et al 32 showed significant correlation between endothelial dysfunction measured by flow-mediated dilatation and ba-PWV. Platelets are also activated by endothelial dysfunction. On the other hand, activated platelets themselves may cause arterial stiffness via vascular smooth muscle cell growth factors and extracellular matrix modulator released from platelets, that is, PDGF. 33 However, this response also occurs at the site of endothelial injury. Further study is therefore required to clarify whether arterial stiffness causes platelet activation or alternatively whether platelet activation might result in arterial stiffness.
Limitations
Despite the small sample size, it is possible that the broad age range (23-77 years) of our subjects caused outliers in PWV and platelet activation. However, significant correlations were found when age and blood pressure were adjusted for, suggesting that the influence of age did not entirely explain the correlation between PWV and platelet activation. In the present study, ba-PWV was 14.173.0 m/s in men and 13.673.1 m/s in women; values higher than those reported by Yamashina et al. 20 Furthermore, it is not known whether such a relationship between arterial stiffness and platelet activation is found in patients with conditions such as hypertension, diabetes mellitus, coronary heart disease, and stroke. Further studies should be therefore performed in such patients, using larger sample sizes.
